Gene · 23523
CABIN1: calcineurin binding protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CABIN1: calcineurin binding protein 1. Genes, record 23523. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23523
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y6J0 | Calcineurin-binding protein cabin-1 | 2,220 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 39511 | Q9Y6J0 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 39512 | Q9Y6J0 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2170 | Q9Y6J0 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 258 | Q9Y6J0 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1739 | Q9Y6J0 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 258 | Q9Y6J0 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1739 | Q9Y6J0 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2170 | Q9Y6J0 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 10483 | Q9Y6J0 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 10485 | Q9Y6J0 | Espacenet |
1 to 10 of 38
See all 38 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants996
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CABIN1 papers | Newest fiscal year |
|---|---|---|---|
| U24CA076518 | A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | 22 | 2025 |
| P01CA018029 | Adult Leukemia Research Center | 13 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 13 | 2025 |
| P01CA078902 | Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30DK026743 | UCSF Liver Center | 7 | 2025 |
| U24HL138660 | Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | 6 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 5 | 2025 |
| P30CA077598 | Cancer Center Support Grant | 5 | 2025 |
1 to 10 of 996Source NIH's project files
See all 996 nih grantsPapers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liver transplantation-related osteoporosis and fragility fractures: pathogenic pathways, risk stratification and novel targeted therapy advances. | Front Immunol | 2026 | 42825020 | PubTator, text mining | PubMed |
| Maintenance of Minimal Manifestation Status with Individualized-Interval Efgartigimod in Generalized Myasthenia Gravis: Study Protocol for a Single-Arm, Open-Label Clinical Trial. | Neurol Ther | 2026 | 42786372 | PubTator, text mining | PubMed |
| Reply: Chronic kidney disease after liver transplantation: Accurate measurement, early acute kidney injury, and renal-protective strategies. | World J Transplant | 2026 | 42751273 | PubTator, text mining | PubMed |
| Conversion From Calcineurin Inhibitor to Ruxolitinib as GVHD Prophylaxis During Patients With Transplant-Associated Thrombotic Microangiopathy. | Transplant Cell Ther | 2026 | 42749189 | PubTator, text mining | PubMed |
| Alcohol-Triggered Periocular Flushing Associated With Tacrolimus 0.1% Ophthalmic Solution in Sjögren-Related Ocular Surface Disease. | Cornea | 2026 | 42746853 | PubTator, text mining | PubMed |
| Associations of IL-2, IL-6 and IL-10 Gene Polymorphisms with Biochemical Parameters and Calcineurin Inhibitor Dosing in Kidney Transplant Recipients. | Biomedicines | 2026 | 42652239 | PubTator, text mining | PubMed |
| Urinary HSP90 as a non-invasive biomarker of active tubular injury in kidney transplant recipients: A multicenter prospective study. | Cell Stress Chaperones | 2026 | 42648627 | PubTator, text mining | PubMed |
| Authors' Reply: Could Calcineurin Inhibitor-Driven Sodium-Chloride Cotransporter Activation Explain Blunted Natriuresis with Sodium-Glucose Cotransporter 2 Inhibition in Kidney Transplant Recipients? | Clin J Am Soc Nephrol | 2026 | 42584954 | PubTator, text mining | PubMed |
| Could Calcineurin Inhibitor-Driven Sodium-Chloride Cotransporter Activation Explain Blunted Natriuresis with SGLT2 Inhibition in Kidney Transplant Recipients? | Clin J Am Soc Nephrol | 2026 | 42584943 | PubTator, text mining | PubMed |
| Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab - A Case Report. | Case Rep Oncol | 2026 | 42569788 | PubTator, text mining | PubMed |
1 to 10 of 2,301
See all 2,301 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23523
GET https://conductscience.org/api/genes/v1/23523/patents?page=2